Sneed Dustin, Wong Carmen
Central Virginia VA Health Care System, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
PM R. 2023 Nov;15(11):1493-1506. doi: 10.1002/pmrj.12965. Epub 2023 May 11.
Platelet-rich plasma (PRP) injections represent a growing interest in the use of biologic therapies for treatment of musculoskeletal injuries. One possible application of PRP is in the management of overuse injuries commonly experienced by athletes. The aim of this review is to evaluate and summarize existing evidence regarding the efficacy of PRP in the treatment of Achilles tendinopathy and plantar fasciitis in athletes. Although many lower quality single-armed studies have demonstrated clinical improvement in athletes treated for Achilles tendinopathy with PRP, higher quality randomized controlled trials (RCTs) have shown no clear benefit in athletes. Existing data suggest PRP significantly improves clinical outcomes for plantar fasciitis in the general population, but very few studies and no RCTs are available that specifically analyze outcomes in athletic populations. More research is needed to evaluate how platelet concentration, leukocyte and erythrocyte presence, and sport type may interact to affect clinical outcomes in athletes.
富血小板血浆(PRP)注射在使用生物疗法治疗肌肉骨骼损伤方面越来越受到关注。PRP的一种可能应用是管理运动员常见的过度使用损伤。本综述的目的是评估和总结关于PRP治疗运动员跟腱病和足底筋膜炎疗效的现有证据。尽管许多质量较低的单臂研究表明,接受PRP治疗的跟腱病运动员临床症状有所改善,但质量较高的随机对照试验(RCT)表明,PRP对运动员并无明显益处。现有数据表明,PRP可显著改善普通人群足底筋膜炎的临床结局,但专门分析运动员群体结局的研究很少,且尚无RCT。需要更多研究来评估血小板浓度、白细胞和红细胞的存在以及运动类型如何相互作用以影响运动员的临床结局。